INJECTION OF ANTI-THY-1.2 ANTIBODY BREAKS RESISTANCE AGAINST HSV INFECTION IN MICE

被引:0
|
作者
CHMIELARCZYK, W
ERNST, R
ZAWATZKY, R
OPITZ, U
KIRCHNER, H
机构
[1] GERMAN CANC RES CTR,INST VIRUS RES,D-6900 HEIDELBERG 1,FED REP GER
[2] BAYER AG,DEPT IMMUNOL & ONCOL,D-5600 WUPPERTAL 1,FED REP GER
[3] MED HIGH SCH WROCLAW,DEPT INTERNAL & OCCUPAT DIS,WROCLAW,POLAND
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:13 / 13
页数:1
相关论文
共 50 条
  • [1] INJECTION OF ANTI-THY-1.2 SERUM BREAKS GENETIC-RESISTANCE OF MICE AGAINST HERPES-SIMPLEX VIRUS
    CHMIELARCZYK, W
    ENGLER, H
    ERNST, R
    OPITZ, U
    KIRCHNER, H
    JOURNAL OF GENERAL VIROLOGY, 1985, 66 (MAY): : 1087 - 1094
  • [2] MONOCLONAL ANTI-THY-1.2 ANTIBODY INDUCED HEMATOPOIESIS INVIVO
    IMAIZUMI, A
    TERADA, S
    KIMOTO, E
    LEUKEMIA RESEARCH, 1988, 12 (01) : 45 - 50
  • [3] IMMUNOMODULATORY PROPERTIES OF MONOCLONAL ANTI-THY-1.2 ANTIBODY INVIVO
    SULA, K
    SOBOTKOVA, E
    SVOBODOVA, M
    NOUZA, K
    IMMUNOBIOLOGY, 1988, 177 (03) : 305 - 316
  • [4] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN NEWBORN MICE TREATED PRENATALLY AND POSTNATALLY WITH ANTI-THY-1.2 MONOCLONAL-ANTIBODY
    CULVER, KW
    SMITH, WL
    COWAN, MJ
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2939 - 2939
  • [5] SOLUBLE LYMPHOMA DERIVED ANTIGEN - IMMUNOGENICITY AND REACTIVITY WITH ANTI-THY-1.2
    BAECHTEL, FS
    GORDON, WC
    GOETZ, G
    PRAGER, MD
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1261 - 1261
  • [6] DIFFERENCES IN HELPER T-CELL SENSITIVITY TO ANTI-THY-1.2 ALLOANTISERUM OR MONOCLONAL-ANTIBODY
    MOTTA, I
    TRUFFABACHI, P
    GUERCIO, PD
    BRUGERE, S
    PERRET, R
    ANNALES D IMMUNOLOGIE, 1980, C131 (03): : 405 - 409
  • [7] COMPARISON OF THE EFFECTS OF ANTI-THY-1.2 MONOCLONAL-ANTIBODY AND XENOGENEIC ANTITHYMOCYTE-SERUM ON THE DEVELOPMENT OF SAI TUMOR ALLOGRAFT IN MICE
    SOBOTKOVA, E
    SULA, K
    NOUZA, K
    NEOPLASMA, 1988, 35 (04) : 361 - 367
  • [8] Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2
    Sharma, Neelesh
    He, Quanren
    Sharma, Raghubir P.
    TOXICOLOGY, 2006, 223 (03) : 191 - 201
  • [9] INVIVO TREATMENT WITH AN APPROPRIATE ANTI-THY-1.2 MONOCLONAL-ANTIBODY ABROGATES HYBRID RESISTANCE TO THY-1.1+ VIRUS-IMMUNE EFFECTOR T-CELLS
    DOHERTY, PC
    ALLAN, JE
    ALLAN, W
    IMMUNOLOGY, 1989, 66 (04) : 631 - 633
  • [10] MONOCLONAL ANTI-THY-1.2 REDUCES LYMPHOPROLIFERATION, RETARDS AUTOIMMUNITY, AND PROLONGS SURVIVAL IN MRL/1PR MICE
    WOFSY, D
    LEDBETTER, JA
    SEAMAN, WE
    CLINICAL RESEARCH, 1983, 31 (02): : A455 - A455